ARCHIVES

NIH Carcinogen Guidelines Offered

This article is from The Cancer Letter archive.

Vol. 07 No. 17 | April 24, 1981

Download PDF Visit The Full Archive

Related Articles

ODAC Votes for Marqibo Accelerated Approval

March 30, 2012

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

September 28, 2001

Organ Systems Support Contract To Cost More than OSCC Grant

September 30, 1988

House Approves 1.9 Percent Increase For NIH.

July 20, 2007

In Brief: Lombardi Comprehensive Designation Renewed; Yale Plans Breast Cancer Lab

September 26, 1997

Funding Opportunities: Department of Defense Ovarian Cancer Research

May 5, 2000